Literature DB >> 28250004

Research in the heart of hematology: chronic myeloid leukemia 2017.

Rüdiger Hehlmann1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28250004      PMCID： PMC5394959          DOI： 10.3324/haematol.2016.159848

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Fused transcript of abl and bcr genes in chronic myelogenous leukaemia.

Authors:  E Shtivelman; B Lifshitz; R P Gale; E Canaani
Journal:  Nature       Date:  1985 Jun 13-19       Impact factor: 49.962

2.  Musculoskeletal pain in patients with chronic myeloid leukemia after discontinuation of imatinib: a tyrosine kinase inhibitor withdrawal syndrome?

Authors:  Johan Richter; Stina Söderlund; Anna Lübking; Arta Dreimane; Kourosh Lotfi; Berit Markevärn; Anders Själander; Susanne Saussele; Ulla Olsson-Strömberg; Leif Stenke
Journal:  J Clin Oncol       Date:  2014-07-28       Impact factor: 44.544

3.  Innovation in hematology. Perspectives: CML 2016.

Authors:  Rüdiger Hehlmann
Journal:  Haematologica       Date:  2016-06       Impact factor: 9.941

4.  Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

Authors:  G Q Daley; R A Van Etten; D Baltimore
Journal:  Science       Date:  1990-02-16       Impact factor: 47.728

Review 5.  Tyrosine kinase inhibition: an approach to drug development.

Authors:  A Levitzki; A Gazit
Journal:  Science       Date:  1995-03-24       Impact factor: 47.728

6.  Impact of unbalanced minor route versus major route karyotypes at diagnosis on prognosis of CML.

Authors:  Alice Fabarius; Lida Kalmanti; Christian T Dietz; Michael Lauseker; Sébastien Rinaldetti; Claudia Haferlach; Gudrun Göhring; Brigitte Schlegelberger; Martine Jotterand; Benjamin Hanfstein; Wolfgang Seifarth; Mathias Hänel; Claus-Henning Köhne; Hans W Lindemann; Wolfgang E Berdel; Peter Staib; Martin C Müller; Ulrike Proetel; Leopold Balleisen; Maria-Elisabeth Goebeler; Jolanta Dengler; Christiane Falge; Lothar Kanz; Andreas Burchert; Michael Kneba; Frank Stegelmann; Michael Pfreundschuh; Cornelius F Waller; Karsten Spiekermann; Tim H Brümmendorf; Matthias Edinger; Wolf-Karsten Hofmann; Markus Pfirrmann; Joerg Hasford; Stefan Krause; Andreas Hochhaus; Susanne Saußele; Rüdiger Hehlmann
Journal:  Ann Hematol       Date:  2015-09-18       Impact factor: 3.673

7.  Treatment and outcome of 2904 CML patients from the EUTOS population-based registry.

Authors:  V S Hoffmann; M Baccarani; J Hasford; F Castagnetti; F Di Raimondo; L F Casado; A Turkina; D Zackova; G Ossenkoppele; A Zaritskey; M Höglund; B Simonsson; K Indrak; Z Sninska; T Sacha; R Clark; A Bogdanovic; A Hellmann; L Griskevicius; G Schubert-Fritschle; D Sertic; J Guilhot; S Lejniece; I Zupan; S Burgstaller; P Koskenvesa; H Everaus; P Costeas; D Lindoerfer; G Rosti; S Saussele; A Hochhaus; R Hehlmann
Journal:  Leukemia       Date:  2016-08-29       Impact factor: 11.528

8.  RNA in human leukemic cells related to the RNA of a mouse leukemia virus (leukocytes-RNA-DNA hybridization-rauscher virus-polysomal RNA).

Authors:  R Hehlmann; D Kufe; S Spiegelman
Journal:  Proc Natl Acad Sci U S A       Date:  1972-02       Impact factor: 11.205

9.  Risk stratification of chromosomal abnormalities in chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy.

Authors:  Wei Wang; Jorge E Cortes; Guilin Tang; Joseph D Khoury; Sa Wang; Carlos E Bueso-Ramos; Joseph A DiGiuseppe; Zi Chen; Hagop M Kantarjian; L Jeffrey Medeiros; Shimin Hu
Journal:  Blood       Date:  2016-03-22       Impact factor: 22.113

10.  Isolation of an SSAV-related endogenous sequence from human DNA.

Authors:  C Leib-Mösch; R Brack; T Werner; V Erfle; R Hehlmann
Journal:  Virology       Date:  1986-12       Impact factor: 3.616
View more
  1 in total

1.  Cytogenetics-based risk prediction of blastic transformation of chronic myeloid leukemia in the era of TKI therapy.

Authors:  Zimu Gong; L Jeffrey Medeiros; Jorge E Cortes; Zi Chen; Lan Zheng; Yan Li; Shi Bai; Pei Lin; Roberto N Miranda; Jeffrey L Jorgensen; Timothy J McDonnell; Wei Wang; Hagop M Kantarjian; Shimin Hu
Journal:  Blood Adv       Date:  2017-12-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.